Significance of increased fibrin/fibrinogen degradation products and presence of fibrin monomers in pregnant women. 1977

L Svanberg, and A Eydal, and B Astedt

Fibrin/fibrinogen degradation products (FDP) and fibrin monomers might occur as a sign of "athological proteolysis" in complicated pregnancies such as toxaemia, hepatosis and placental insufficiency, eut also in otherwise clinically uncomplicated pregnancies. 18 pregnant women with increased proteolysis, but without any other clinical symptoms of complications were therefore investigated to determine the outcome of their pregnancies. The investigation showed that proteolysis with moderately increased serum FDP and fibrin monomers but without any other clinical signs of complications of pregnancy need not necessarily imply any risk to the mother or the foetus.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D005260 Female Females
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Svanberg, and A Eydal, and B Astedt
January 1974, Vutreshni bolesti,
L Svanberg, and A Eydal, and B Astedt
February 1972, Polskie Archiwum Medycyny Wewnetrznej,
L Svanberg, and A Eydal, and B Astedt
January 1980, Annals of clinical and laboratory science,
L Svanberg, and A Eydal, and B Astedt
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
L Svanberg, and A Eydal, and B Astedt
January 1973, Rinsho byori. The Japanese journal of clinical pathology,
L Svanberg, and A Eydal, and B Astedt
October 1972, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
L Svanberg, and A Eydal, and B Astedt
January 1982, Sovetskaia meditsina,
L Svanberg, and A Eydal, and B Astedt
January 1979, Vutreshni bolesti,
L Svanberg, and A Eydal, and B Astedt
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
L Svanberg, and A Eydal, and B Astedt
December 1989, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!